背景:水痘发病率的增加强调了理解和有效解决预防的关键需求,早期发现,和对这种疾病的敏捷反应。因此,本研究旨在确定对水痘的知识和态度。
方法:使用诸如PubMed,Scopus,WebofScience,Embase,和科学直接,更新搜索,直到2023年6月25日。纳入的观察性研究的质量使用JoannaBriggs研究所的统计荟萃分析综述工具进行评估。收集的数据记录在MicrosoftExcel电子表格中,并使用R软件4.2.3版进行分析。此外,Cochran的Q统计量用于评估纳入研究的异质性。
结果:共从5个数据库中检索到299篇文章。这项研究包括27篇横断面文章,总样本为22,327名参与者,其中57.13%是女性。这些研究是通过在线调查在15个国家进行的。所有研究都具有中等质量水平。关于水痘的知识水平良好的综合患病率为33%(95%CI:22%-45%;22,327名参与者;27项研究;I2=100%),对水痘持积极态度的总患病率为40%(95%CI:19%-62%;2,979名参与者;6项研究;I2=99%).此外,作为次要结果,拟接种水痘疫苗的总患病率为58%(95%CI:37%-78%;2,932名参与者;7项研究;I2=99%).
结论:发现对水痘的良好知识和积极态度较低。这项研究的结果强调了需要确定差距并专注于实施关于水痘的教育计划。
■JoannaBriggsInstituteMeta分析统计评估和审查工具(JBI-MAStARI),前瞻性国际系统审查登记处(PROSPERO),系统评价和荟萃分析(PRISMA)的首选报告项目。
BACKGROUND: The increase in mpox incidence underscores the crucial need to understand and effectively address prevention, early detection, and agile response to this disease. Therefore, the present study aims to determine the knowledge and attitude towards mpox.
METHODS: A systematic review and comprehensive literature meta-analysis were conducted using prominent databases such as PubMed, Scopus, Web of Science, Embase, and ScienceDirect, with an updated search until June 25, 2023. The quality of the included observational studies was assessed using the Joanna Briggs Institute\'s Statistical Meta-Analysis Review Instrument. The collected data were recorded in a Microsoft Excel spreadsheet, and analyses were conducted using R software version 4.2.3. Additionally, Cochran\'s Q statistics were applied to assess the heterogeneity of the included studies.
RESULTS: A total of 299 articles were retrieved from 5 databases. This study included 27 cross-sectional articles with a total sample of 22,327 participants, of which 57.13% were women. The studies were conducted in 15 countries through an online survey. All studies had a moderate level of quality. The combined prevalence of a good level of knowledge about mpox was 33% (95% CI: 22%-45%; 22,327 participants; 27 studies; I2 = 100%), and the combined prevalence of a positive attitude towards mpox was 40% (95% CI: 19%-62%; 2,979 participants; 6 studies; I2 = 99%). Additionally, as a secondary outcome, the combined prevalence of the intention to vaccinate against mpox was 58% (95% CI: 37%-78%; 2,932 participants; 7 studies; I2 = 99%).
CONCLUSIONS: Good knowledge and a positive attitude towards mpox were found to be low. The findings of this study highlight the need to identify gaps and focus on implementing educational programs on mpox.
UNASSIGNED: Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI), Prospective International Registry of Systematic Reviews (PROSPERO), and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).